These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
123 related items for PubMed ID: 7502426
1. Chromosomal anomalies in atypical adenomatous hyperplasia and carcinoma of the prostate using fluorescence in situ hybridization. Qian J, Jenkins RB, Bostwick DG. Urology; 1995 Dec; 46(6):837-42. PubMed ID: 7502426 [Abstract] [Full Text] [Related]
2. Detection of chromosomal anomalies and c-myc gene amplification in the cribriform pattern of prostatic intraepithelial neoplasia and carcinoma by fluorescence in situ hybridization. Qian J, Jenkins RB, Bostwick DG. Mod Pathol; 1997 Nov; 10(11):1113-9. PubMed ID: 9388062 [Abstract] [Full Text] [Related]
4. Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization. Jenkins RB, Qian J, Lieber MM, Bostwick DG. Cancer Res; 1997 Feb 01; 57(3):524-31. PubMed ID: 9012485 [Abstract] [Full Text] [Related]
10. Associations among benign prostate hypertrophy, atypical adenomatous hyperplasia and latent carcinoma of the prostate. Stamatiou K, Alevizos A, Natzar M, Mihas C, Mariolis A, Michalodimitrakis E, Sofras F. Asian J Androl; 2007 Mar 01; 9(2):229-33. PubMed ID: 16751999 [Abstract] [Full Text] [Related]
11. Premalignant lesions of prostate and their association with nodular hyperplasia and carcinoma prostate. Rekhi B, Jaswal TS, Arora B. Indian J Cancer; 2004 Mar 01; 41(2):60-5. PubMed ID: 15318010 [Abstract] [Full Text] [Related]
12. Relationship between atypical adenomatous hyperplasia (AAH), prostatic intraepithelial neoplasia (PIN) and prostatic adenocarcinoma. Helpap B, Bonkhoff H, Cockett A, Montironi R, Troncoso P, Waters D, Bostwick D. Pathologica; 1997 Jun 01; 89(3):288-300. PubMed ID: 9270265 [Abstract] [Full Text] [Related]
13. Aneuploidy and aneusomy of chromosome 7 detected by fluorescence in situ hybridization are markers of poor prognosis in prostate cancer. Alcaraz A, Takahashi S, Brown JA, Herath JF, Bergstralh EJ, Larson-Keller JJ, Lieber MM, Jenkins RB. Cancer Res; 1994 Aug 01; 54(15):3998-4002. PubMed ID: 7518348 [Abstract] [Full Text] [Related]
15. Atypical adenomatous hyperplasia of prostate lacks TMPRSS2-ERG gene fusion. Cheng L, Davidson DD, Maclennan GT, Lopez-Beltran A, Montironi R, Wang M, Tan PH, Baldridge LA, Zhang S. Am J Surg Pathol; 2013 Oct 01; 37(10):1550-4. PubMed ID: 23887154 [Abstract] [Full Text] [Related]
16. Potential markers of prostate cancer aggressiveness detected by fluorescence in situ hybridization in needle biopsies. Takahashi S, Qian J, Brown JA, Alcaraz A, Bostwick DG, Lieber MM, Jenkins RB. Cancer Res; 1994 Jul 01; 54(13):3574-9. PubMed ID: 8012984 [Abstract] [Full Text] [Related]